2542. Attenuation of Polymyxin and Aminoglycoside-Associated Nephrotoxicity

BACKGROUND: The clinical use of aminoglycosides and polymyxins to treat multidrug-resistant Gram-negative bacterial infections is hindered by dose-limiting nephrotoxicity. Recently, there has been increased interest in reducing the nephrotoxic potential of these antibiotics to combat the antimicrobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hudson, Cole, Smith, James E, Eales, Brianna, Liu, Xinli, Kajiji, Shama, Truong, Luan, Tam, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678801/
http://dx.doi.org/10.1093/ofid/ofad500.2159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678801/
http://dx.doi.org/10.1093/ofid/ofad500.2159

Ejemplares similares